Acromegaly - 140 Studies Found Terminated : Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas : Acromegaly : 2005-10-09 : Drug: Octreotide acetate Other Name: SMS995 Withdrawn : Study to Evaluate Patients With Acromegaly Treated With Lanreotide Autogel (Somatuline ATG) : Acromegaly : 2007-08-16 : Drug: lanreotide (Autogel formulation) 120 mg administered every 28 days via deep subcutaneous injection Recruiting : Assessment of Changes in Metabolic Activity in Liver & Skeletal Muscle in Patients Suffering From Acromegaly : Acromegaly : 2014-04-11 : Other: 1H/31P Magnetic Resonance Spectroscopy Recruiting : Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly : Acromegaly : 2016-11-10 : Drug: BIM23B065 Subcutaneous twice a day or three times a day administration of BIM23B065. Dose will be Completed : Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly : Acromegaly : 2015-07-07 : Drug: Lanreotide Autogel® Completed : A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreotide : Acromegaly : 2005-10-05 Recruiting : Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly : Acromegaly : 2015-03-18 : Drug: Lanreotide PRF Other Name: Lanreotide acetate Completed : Physiopathology of Sodium Retention in Acromegaly : Acromegaly : 2007-09-18 : Drug: furosemide furosemide Completed : Description of the Association of Signs and Symptoms Present at Acromegaly Diagnosis : Acromegaly : 2013-11-28 Active, not recruiting : Ectopic Lipid Deposition and Insulin Resistance in After Treatment of Acromegaly : Acromegaly : 2013-03-22 <<< Previous | Next >>>
